Exploring the promising role of non-platinum metal complexes like ruthenium and gold in cancer therapy, their mechanisms, and clinical progress.
Exploring how molecular conformation dynamics are transforming cancer drug design, with focus on M1 aminopeptidase inhibitors.
Discover the groundbreaking binary BMVC-porphyrin photosensitizer that combines cancer detection and treatment in a single molecular system.
Exploring Biotin-SN38-Valproic Acid Conjugates as a targeted cancer therapy approach combining chemotherapy, epigenetic modulation, and precise delivery.
Novel DNA-PK inhibitor combined with radiation therapy demonstrates potent synergy against glioblastoma and lung cancer in preclinical studies.